Y-Intercept (HK)’s Dyne Therapeutics DYN Stock Holding History

Y-Intercept (HK)’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$948K	Sell	58,861 -97,342	-62%	-$2.24M	0.02%	1036
2026 Q2	$3.47M	Buy	156,203 +91,045	+140%	+$1.69M	0.07%	420
2026 Q1	$1.18M	Sell	65,158 -278,568	-81%	-$4.8M	0.02%	954
2025 Q4	$6.72M	Buy	+343,726	New	+$6.51M	0.15%	139
2025 Q3	–	Sell	-124,628	Closed	-$1.19M	–	1679
2025 Q2	$1.19M	Buy	124,628 +43,963	+55%	+$484K	0.03%	857
2025 Q1	$844K	Buy	80,665 +70,897	+726%	+$1.01M	0.06%	477
2024 Q4	$230K	Sell	9,768 -19,926	-67%	-$589K	0.02%	1013
2024 Q3	$1.07M	Buy	+29,694	New	+$1.18M	0.07%	425

Other funds holding DYN

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return

Y-Intercept (HK)'s DYN Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Dyne Therapeutics (DYN) stake by 62% in Q3 2026, selling an estimated $2.24M and leaving 58,861 shares worth $948K. The position accounts for 0.02% of the portfolio, ranked #1036.

Y-Intercept (HK) first reported a position in DYN in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.72M in Q4 2025. 61 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

Y-Intercept (HK) held 58,861 shares of Dyne Therapeutics worth $948K as of Q3 2026.
Y-Intercept (HK) sold 97,342 Dyne Therapeutics shares in Q3 2026, an estimated $2.24M.
Dyne Therapeutics made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1036 holding.
Y-Intercept (HK) first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 8 quarters since.
Y-Intercept (HK)'s Dyne Therapeutics position peaked at $6.72M in Q4 2025.
61 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.